Brief: Intervacc's Vaccine Gets U.S. Patent Approval

Intervacc AB

23/11/2023 08:02

Nov 23 (Reuters) - INTERVACC AB  IVACC.ST :
    * SAID ON WEDNESDAY THE UNITED STATES PATENT AND TRADEMARK
OFFICE
HAS GRANTED AN APPROVAL FOR INTERVACC'S VACCINE AGAINST
STREPTOCOCCUS SUIS INFECTIONS IN PIGS
    * THE U.S. PATENT NO. 11,814,415 RELATES TO A VACCINE BASED
ON
RECOMBINANT FUSION PROTEINS 
    * PATENT PROTECTION IS EFFECTIVE UNTIL 2037

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkr1QJzzp
 Further company coverage:  IVACC.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))